These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 26318068)

  • 1. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J; Singla R; Kumar M; Jaitak V
    Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
    Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
    Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
    Thakur A; Singla R; Jaitak V
    Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumarin derivatives with anticancer activities: An update.
    Song XF; Fan J; Liu L; Liu XF; Gao F
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G; Sun S; Wu B; Liu J
    Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
    Paul K; Bindal S; Luxami V
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
    Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
    Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Cytotoxic Evaluation of Pyran, Dihydropyridine and Thiophene Derivatives of 3-Acetylcoumarin.
    Mohareb RM; Megally Abdo NY
    Chem Pharm Bull (Tokyo); 2015; 63(9):678-87. PubMed ID: 26329861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
    Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
    Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
    Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anticancer activity of 6-heteroarylcoumarins.
    Galayev O; Garazd Y; Garazd M; Lesyk R
    Eur J Med Chem; 2015 Nov; 105():171-81. PubMed ID: 26491980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.
    Serra S; Chicca A; Delogu G; Vázquez-Rodríguez S; Santana L; Uriarte E; Casu L; Gertsch J
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5791-4. PubMed ID: 22901895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
    Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
    Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F; Huo X; Guo Z
    Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
    Lv N; Sun M; Liu C; Li J
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
    Tugcu G; Sipahi H; Aydin A
    Curr Top Med Chem; 2019; 19(13):1121-1128. PubMed ID: 31210111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
    Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A
    Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.